StockData
Calidi Biotherapeutics, Inc. logo

Calidi Biotherapeutics, Inc. (CLDI) stock

CLDINYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as CLDWW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 3/30
$0.51−0.02 (-4.23%)

Close on Nov 19, 2026Market cap $1.31MP/E –Yield –

Calidi Biotherapeutics shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Calidi Biotherapeutics's shares outstanding was 1M at Jun 30, 2026. For fiscal 2025 it was 0M, up 545.0% from the year before.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 20250M+545.0%
FY2024Dec 31, 20240M-100.0%
FY2023Dec 31, 20232M+98.2%
FY2022Dec 31, 20221M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 20261M+686.7%
Q1 FY2026Mar 31, 202610M+356.7%
Q4 FY2025Dec 31, 20250M+459.5%
Q3 FY2025Sep 30, 20250M+652.6%
Q2 FY2025Jun 30, 20250M+40440.5%
Q1 FY2025Mar 31, 20252M+63388.0%
Q4 FY2024Dec 31, 20240M-99.9%
Q3 FY2024Sep 30, 20240M-99.9%
Q2 FY2024Jun 30, 20240M-99.9%
Q1 FY2024Mar 31, 20240M-99.6%
Q3 FY2023Sep 30, 20231M+67.1%
Q2 FY2023Jun 30, 20231M–
Q1 FY2023Mar 31, 20231M–
Q4 FY2022Dec 31, 20221M–
Q3 FY2022Sep 30, 20221M–

More Calidi Biotherapeutics figures

See a number that looks wrong?